Measles Vaccine
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella) (NCT05154097) | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2022-01-04 |
| Measles Vaccination at Health System Contacts (NCT04220671) | Bandim Health Project | 2020-01-08 |
| Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso. (NCT01668745) | Bandim Health Project | 2013-05-03 |
Track Measles Vaccine automatically
Every clearance here is in the API, with alerts when new ones post.